Liquid and vapour-phase antifungal activities of essential oils against Candida albicans and non-albicans Candida

BACKGROUND: The management of Candida infections faces many problems, such as a limited number of antifungal drugs, toxicity, resistance of Candida to commonly antifungal drugs, relapse of Candida infections, and the high cost of antifungal drugs. Though azole antifungal agents and derivatives conti...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:BMC Complement Altern Med
Autors principals: Mandras, Narcisa, Nostro, Antonia, Roana, Janira, Scalas, Daniela, Banche, Giuliana, Ghisetti, Valeria, Del Re, Simonetta, Fucale, Giacomo, Cuffini, Anna Maria, Tullio, Vivian
Format: Artigo
Idioma:Inglês
Publicat: BioMed Central 2016
Matèries:
Research Article
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC5006570/
https://ncbi.nlm.nih.gov/pubmed/27576581
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12906-016-1316-5
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars